| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/08/2010 | US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity |
| 04/08/2010 | US20100087431 Triazolyl aminopyrimidine compounds |
| 04/08/2010 | US20100087430 Novel benzofuran potassium channel blockers and uses thereof |
| 04/08/2010 | US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 04/08/2010 | US20100087425 Substituted N-Arylsulfonylheterocyclic Amines As Gamma-Secretase Inhibitors |
| 04/08/2010 | US20100087417 Amino-pyridine derivatives as s1p1 /edg1 receptor agonists |
| 04/08/2010 | US20100087360 Heterocycle-substituted benzimidazole derivative |
| 04/08/2010 | CA2739322A1 Compounds for inflammation and immune-related uses |
| 04/08/2010 | CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| 04/08/2010 | CA2738563A1 8-substituted isoquinoline derivatives and the use thereof |
| 04/08/2010 | CA2738348A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/08/2010 | CA2738313A1 Viral and fungal inhibitors |
| 04/08/2010 | CA2737480A1 Novel compounds as calcium channel blockers |
| 04/07/2010 | EP2172456A1 N-phenyl-methanamine derivative and pest control agent containing the same |
| 04/07/2010 | EP2172448A1 Substituted isoxazoline or enone oxime compound, and pest control agent |
| 04/07/2010 | EP2170877A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 04/07/2010 | EP2170876A2 Pharmaceutical composition for preventintion and treatment of restenosis comprising isoxazole derivatives |
| 04/07/2010 | EP2170875A1 Aminoalkylazole derivatives as histamine-3 antagonists |
| 04/07/2010 | EP2170874A2 Novel compounds and their use |
| 04/07/2010 | EP2170861A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 04/07/2010 | EP2170850A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists |
| 04/07/2010 | EP2170849A1 Oxazole tyrosine kinase inhibitors |
| 04/07/2010 | EP2170848A1 Pyrazinone derivatives and their use in the treatment of lung diseases |
| 04/07/2010 | EP2170843A1 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 04/07/2010 | EP2170842A1 Protein kinase inhibitors and methods for using thereof |
| 04/07/2010 | EP2170823A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 04/07/2010 | EP2170814A2 Antibacterial agents |
| 04/07/2010 | EP2170072A1 Farnesoid x receptor agonists |
| 04/07/2010 | EP2170066A2 Pesticides and uses thereof |
| 04/07/2010 | EP2170065A1 Diphenyl substituted alkanes |
| 04/07/2010 | EP2170058A1 Cetp inhibitors derived from benzoxazole arylamides |
| 04/07/2010 | EP1551829B1 Novel compounds with antibacterial activity |
| 04/07/2010 | EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 04/07/2010 | CN101691366A Quinoxaline derivative, and light-emitting element and electronic device using the same |
| 04/06/2010 | US7692029 Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/06/2010 | US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent |
| 04/06/2010 | US7692022 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations |
| 04/06/2010 | US7692011 8-hydroxy and 8-mercapto quinazolinones |
| 04/06/2010 | US7692005 Kinase inhibitors |
| 04/06/2010 | US7691889 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide |
| 04/06/2010 | US7691882 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells |
| 04/06/2010 | US7691854 Diethyl 2-amino-4-(4-cyanophenyl)-6-methyl-1-(3-methylphenyl)-1,4-dihydro-3,5-pyridine-dicarboxylate; chronic obstructive pulmonary disease, acute coronary syndrome, acute myocardial infarction or development of heart failure |
| 04/06/2010 | US7691852 Compounds for enzyme inhibition |
| 04/06/2010 | US7691849 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 04/06/2010 | US7691846 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 04/06/2010 | US7691841 Azetidine derivatives as CCR-3 receptor antagonist |
| 04/06/2010 | US7691785 Pyridine-3-ketone compound; plant growth controllers |
| 04/06/2010 | CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors |
| 04/06/2010 | CA2453383C Piperidine derivatives as nmda receptor antagonists |
| 04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/06/2010 | CA2252536C Ethylene derivatives and pesticides containing said derivatives |
| 04/01/2010 | WO2010037129A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | WO2010036908A1 Use of benzoxazole compounds in the treatment of malaria |
| 04/01/2010 | WO2010036905A1 Benzoxazole compounds and methods of use |
| 04/01/2010 | WO2010036631A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036630A2 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | WO2010036613A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 04/01/2010 | WO2010035899A1 Pyridine compound and use thereof for pest control |
| 04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |
| 04/01/2010 | WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 04/01/2010 | WO2010034838A2 New chemical compounds |
| 04/01/2010 | WO2010034671A1 Pyrine or pyrazine derivatives for treating hcv |
| 04/01/2010 | WO2010034646A1 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors |
| 04/01/2010 | WO2010010157A3 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
| 04/01/2010 | WO2010002655A3 Pyrimidine derivatives as kinase inhibitors |
| 04/01/2010 | US20100081807 Method for producing 5-cloro-n-(methyl)-2-thiophenecarboxamide |
| 04/01/2010 | US20100081806 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 04/01/2010 | US20100081805 Preparation of a Quinolinyloxydiphenylcyclopropanedicarboxamide |
| 04/01/2010 | US20100081690 Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 04/01/2010 | US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter |
| 04/01/2010 | US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 04/01/2010 | US20100081659 Sigma receptor inhibitors |
| 04/01/2010 | US20100081658 Heterocyclic antiviral compounds |
| 04/01/2010 | US20100081657 Quinoxalines useful as inhibitors of protein kinases |
| 04/01/2010 | US20100081656 Compositions and methods for modulating c-kit and pdgfr receptors |
| 04/01/2010 | US20100081653 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors |
| 04/01/2010 | US20100081646 Bicyclic heteroaryl inhibitors of pde4 |
| 04/01/2010 | US20100081644 Compounds Which Selectively Modulate The CB2 Receptor |
| 04/01/2010 | US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 04/01/2010 | US20100081641 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer |
| 04/01/2010 | US20100080772 Hepatitis C Virus Inhibitors |
| 04/01/2010 | CA2738809A1 Quinazolinone, quinolone and related analogs as sirtuin modulators |
| 04/01/2010 | CA2738448A1 New chemical compounds |
| 04/01/2010 | CA2737694A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 04/01/2010 | CA2737645A1 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | CA2737639A1 Compounds which selectively modulate the cb2 receptor |
| 04/01/2010 | CA2736724A1 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors |
| 04/01/2010 | CA2736472A1 Pyrine or pyrazine derivatives for treating hcv |
| 03/31/2010 | EP2168962A2 Phenylacetamides and their use as glucokinase modulators |
| 03/31/2010 | EP2168952A1 Morpholine derivative |
| 03/31/2010 | EP2168947A1 Novel compound having secretase inhibitory activity |
| 03/31/2010 | EP2167502A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842 |
| 03/31/2010 | EP2167501A1 Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators - 841 |
| 03/31/2010 | EP2167500A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders |
| 03/31/2010 | EP2167499A2 Substituted oxazolidinones and use thereof |
| 03/31/2010 | EP2167498A1 Compounds and compositions as itpkb inhibitors |
| 03/31/2010 | EP2167497A2 Heterocyclic compounds useful as raf kinase inhibitors |
| 03/31/2010 | EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 03/31/2010 | EP2167491A1 5-heteroaryl substituted indazoles as kinase inhibitors |
| 03/31/2010 | EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |